Last Minute Stuff - Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy. (Ny Times Science) More

Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

Similar stories

Is Lilly Stock A Buy After Weight-Loss Drug Beats Sales Views? - Investor's Business Daily

Study: Zepbound Reduces Sleep Apnea Symptoms - Prevention Magazine

Weight-loss drug linked to sleep apnea reduction: Research - Yahoo News Australia

Weight Loss Drugs Zepbound and Mounjaro Are in Shortage Due to 'Demand Increase,' FDA Says - Yahoo News Canada

Zepbound and Mounjaro Might Help Reduce Obstructive Sleep Apnea Symptoms - Everyday Health

Sleep apnea: Zepbound, Mounjaro improves symptoms in clinical trial - Medical News Today